However, evidence is currently limited
This helpful tool tracks your response to GLP-1 medications, allowing you to manage side effects, adjust dosing, and determine when to stop treatment based on your personal experience
by Jennifer Lines, PharmD Candidate, PCCA Clinical Services Intern, and Catherine Henderson, PharmD, PCCA Clinical Compounding Pharmacist Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized metabolic health and weight management, leading to a host of new weight loss wonder drugs
A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion
At LCS Medical Spa, we understand the importance of personalized care and evidence-based treatments to help our clients achieve their health, wellness, and aesthetic goals
Book your free consultation Individual results vary and are not guaranteed